Healthcare
RIGL
Rigel Pharmaceuticals, Inc.
$46.48-0.81%
Add to Watchlist
Loading chart...
About Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals develops medicines for blood disorders and certain cancers. The company sells three approved drugs: Tavalisse for a condition where the immune system attacks blood platelets, Rezlidhia for a type of blood cancer, and Gavreto for certain lung and thyroid cancers. It is also testing other experimental drugs for blood cancers and immune diseases.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore